Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease

Chung, Kenny K.K., Zhang, Yi, Lim, Kah Leong, Tanaka, Yuji, Huang, Hui, Gao, Jun, Ross, Christopher A., Dawson, Valina L. +1 more·2001·Nature Medicine

Cited by (744)

Items 201–300 of 744

  1. Lewy Body–like Inclusions in Human Midbrain Organoids Carrying Glucocerebrosidase and α‐Synuclein Mutations
    Junghyun Jo, Lin Yang, Hoang‐Dai Tran, Weonjin Yu, Alfred Xuyang Sun, Ya Yin Chang, Byung Chul Jung, Seung‐Jae Lee, Tzuen Yih Saw, Bin Xiao et al. · 2021 · Annals of Neurology
  2. Crosstalk Between Macroautophagy and Chaperone-Mediated Autophagy: Implications for the Treatment of Neurological Diseases
    Haijian Wu, Sheng Chen, Ammar Al-Baadani, Jie Xu, Qun Wu, Kum Pan, Jianmin Zhang, Yuan Hong · 2014 · Molecular Neurobiology
  3. Parkin Ubiquitinates and Promotes the Degradation of RanBP2
    Ji Won Um, Do Sik Min, Hyewhon Rhim, Jongsun Kim, Seung R. Paik, Kwang Chul Chung · 2005 · Journal of Biological Chemistry
  4. Pathogenesis of familial Parkinson’s disease: new insights based on monogenic forms of Parkinson’s disease
    Taku Hatano, Shinichiro Kubo, Shigeto Sato, Nobutaka Hattori · 2009 · Journal of Neurochemistry
  5. Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease
    Idit Ron, D. Rapaport, Mia Horowitz · 2010 · Human Molecular Genetics
  6. Parkin Regulates Mitosis and Genomic Stability through Cdc20/Cdh1
    Seung Baek Lee, Jung Jin Kim, Hyun-Ja Nam, Bowen Gao, Ping Yin, Bo Qin, Sang Yeop Yi, Hyoungjun Ham, Debra L. Evans, Sun‐Hyun Kim et al. · 2015 · Molecular Cell
  7. Down-regulation of α-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson’s disease rat model
    Hiromi Hayashita‐Kinoh, Masanori YAMADA, Takanori Yokota, Yoshikuni Mizuno, Hideki Mochizuki · 2006 · Biochemical and Biophysical Research Communications
  8. Synaptic vesicle trafficking and Parkinson's disease
    Giovanni Esposito, Fernandes Ana Clara, Patrik Verstreken · 2011 · Developmental Neurobiology
  9. Parkin protects dopaminergic neurons from excessive Wnt/β-catenin signaling
    Nina Rawal, Olga Corti, Paola Sacchetti, Héctor Ardila-Osorio, Bita Sehat, Alexis Brice, Ernest Arenas · 2009 · Biochemical and Biophysical Research Communications
  10. Parkin reverses intracellular β‐amyloid accumulation and its negative effects on proteasome function
    Kenneth M. Rosen, Charbel Moussa, Hankyu Lee, Pravir Kumar, Tohru Kitada, Gangjian Qin, Qinghao Fu, Henry W. Querfurth · 2009 · Journal of Neuroscience Research
  11. Triggering Aggresome Formation
    Nava Zaarur, Anatoli B. Meriin, Vladimir L. Gabai, Michael Y. Sherman · 2008 · Journal of Biological Chemistry
  12. Synphilin-1 attenuates neuronal degeneration in the A53T -synuclein transgenic mouse model
    W. W. Smith, Zhong Wu Liu, Yajie Liang, Naoki Masuda, Deborah A. Swing, Nancy A. Jenkins, Neal G. Copeland, Juan Carlos Troncoso, Mikhail V. Pletnikov, Ted M. Dawson et al. · 2010 · Human Molecular Genetics
  13. Molecular Features Underlying Neurodegeneration Identified through In Vitro Modeling of Genetically Diverse Parkinson’s Disease Patients
    Lin Lin, Jonathan Göke, Engin Cukuroglu, Mark R. Dranias, Antonius M.J. VanDongen, Lawrence Walter Stanton · 2016 · Cell Reports
  14. Loss of Parkin contributes to mitochondrial turnover and dopaminergic neuronal loss in aged mice
    Sachiko Noda, Shigeto Sato, Takahiro Fukuda, Norihiro Tada, Yasuo Uchiyama, Keiji Tanaka, Nobutaka Hattori · 2019 · Neurobiology of Disease
  15. Caspase-1 and Caspase-8 Cleave and Inactivate Cellular Parkin
    Søren Kahns, Michaël Kalai, Lene Diness Jakobsen, Brian F.C. Clark, Peter Vandenabeele, Poul Henning Jensen · 2003 · Journal of Biological Chemistry
  16. Genetic contributions to Parkinson's disease
    Yue Ming Huang, Linda Cheung, Dominic B. Rowe, Glenda Margaret Halliday · 2004 · Brain Research Reviews
  17. Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation
    Gaetano Calabrese, Cristen M. Molzahn, Thibault Mayor · 2022 · Journal of Biological Chemistry
  18. Identification of Common Biological Pathways and Drug Targets Across Multiple Respiratory Viruses Based on Human Host Gene Expression Analysis
    Steven B. Smith, William Dampier, Aydın Tözeren, James R. Brown, Michal Magid-Slav · 2012 · PLoS ONE
  19. Inclusion Body Formation and Neurodegeneration Are Parkin Independent in a Mouse Model of α-Synucleinopathy
    Rainer von Coelln, Bobby Thomas, Shaida A. Andrabi, Kah Leong Lim, Joseph M. Savitt, Roya Saffary, Wanda L.H. Stirling, Kristy J. Bruno, Ellen J. Hess, Michael K. Lee et al. · 2006 · Journal of Neuroscience
  20. Nosology of Parkinson’s Disease: Looking for the Way Out of a Quackmire
    Mark S. Forman, Virginia M.‐Y. Lee, John Q. Trojanowski · 2005 · Neuron
  21. Genes associated with Parkinson syndrome
    Saskia Biskup, Manfred Gerlach, Andreas R. Kupsch, Heinz Reichmann, Peter Franz Riederer, P. Vieregge, Ullrich Wüllner, Thomas Gasser · 2008 · Journal of Neurology
  22. Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model
    Preeti J. Khandelwal, Sonya B. Dumanis, Li Feng, Kathleen A. Maguire‐Zeiss, George William Rebeck, Hilal Ahmed Lashuel, Charbel Moussa · 2010 · Molecular Neurodegeneration
  23. Astrocytic but not neuronal increased expression and redistribution of parkin during unfolded protein stress
    María Dolores Ledesma, Cristian A. Galván, Bianca Hellias, Carlos G. Dotti, Poul Henning Jensen · 2002 · Journal of Neurochemistry
  24. K63-linked ubiquitination and neurodegeneration
    Kah‐Leong Lim, Grace G.Y. Lim · 2010 · Neurobiology of Disease
  25. The effects of oxidative stress on parkin and other E3 ligases
    Matthew J. LaVoie, Giuseppe P. Cortese, Beth L. Ostaszewski, Michael G. Schlossmacher · 2007 · Journal of Neurochemistry
  26. Does Impairment of the Ubiquitin-Proteasome System or the Autophagy-Lysosome Pathway Predispose Individuals to Neurodegenerative Disorders such as Parkinson's Disease?
    Noriyuki Matsuda, Keiji Tanaka · 2010 · Journal of Alzheimer s Disease
  27. Convergence of Parkin, PINK1, and α-Synuclein on Stress-induced Mitochondrial Morphological Remodeling
    Kristi L. Norris, Rui Hao, Liangfu Chen, Chun-Hsiang Lai, Meghan Kapur, Peter J. Shaughnessy, Dennis Chou, Jin Yan, J. Paul Taylor, Simone Engelender et al. · 2015 · Journal of Biological Chemistry
  28. Models of Parkinson's disease
    Michael Orth, Sarah J. Tabrizi · 2003 · Movement Disorders
  29. Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease
    Katrin Beyer, Montserrat Domingo-Sàbat, Jordi Humbert, Cristina Carrato, Isidró Ferrer, Aurelio Ariza · 2008 · Neurogenetics
  30. Interaction between Parkin and α-Synuclein in PARK2-Mediated Parkinson’s Disease
    Daniel Aghaie Madsen, Sissel Ida Schmidt, Morten Blaabjerg, Morten Meyer · 2021 · Cells
  31. Prolyl-isomerase Pin1 Accumulates in Lewy Bodies of Parkinson Disease and Facilitates Formation of α-Synuclein Inclusions
    Akihide Ryo, Takashi Togo, Toshiki Nakai, Akiko Hirai, Mayuko Nishi, Akira Yamaguchi, Kyoko Suzuki, Yoshio Hirayasu, Hideki Kobayashi, Kilian Perrem et al. · 2005 · Journal of Biological Chemistry
  32. The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders
    Kenny K. K. Chung, Valina Lynn Dawson, Ted M. Dawson · 2001 · Trends in Neurosciences
  33. Parkin Protects against Mitochondrial Toxins and β-Amyloid Accumulation in Skeletal Muscle Cells
    Kenneth M. Rosen, Vimal Veereshwarayya, Charbel Moussa, Qinghao Fu, Matthew S. Goldberg, Michael G. Schlossmacher, Jie Shen, Henry W. Querfurth · 2006 · Journal of Biological Chemistry
  34. Progress in the pathogenesis and genetics of Parkinson's disease
    Yoshikuni Mizuno, Nobutaka Hattori, Shinichiro Kubo, Shigeto Sato, Kenya Nishioka, Taku Hatano, Hiroyuki Tomiyama, Manabu Funayama, Yutaka Machida, Hideki Mochizuki · 2008 · Philosophical Transactions of the Royal Society B Biological Sciences
  35. The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates
    Wen‐Jie Gu, Olga Corti, Francisco Araujo, Cornelia Hampe, Sandrine Jacquier, Christoph B. Lücking, N. Abbas, Charles J. Duyckaerts, Thomas Rooney, Laurent Pradier et al. · 2003 · Neurobiology of Disease
  36. Endoplasmic reticulum-associated protein degradation
    Ernst Jarosch, Uwe Lenk, Thomas Sommer · 2002 · International review of cytology
  37. Role of Ubiquitin–Proteasome and Autophagy-Lysosome Pathways in α-Synuclein Aggregate Clearance
    Subhashree Sahoo, Amrita Arpita Padhy, Varsha Kumari, Parul Mishra · 2022 · Molecular Neurobiology
  38. Parkin Regulation and Neurodegenerative Disorders
    Chengwu Zhang, Liting Hang, Tso‐Pang Yao, Kah‐Leong Lim · 2016 · Frontiers in Aging Neuroscience
  39. Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival
    Miratul M. K. Muqit · 2003 · Human Molecular Genetics
  40. Basic Fibroblast Growth Factor Protects against Rotenone-Induced Dopaminergic Cell Death through Activation of Extracellular Signal-Regulated Kinases 1/2 and Phosphatidylinositol-3 Kinase Pathways
    Shih‐Ling Hsuan, Heather M. Klintworth, Zhengui Xia · 2006 · Journal of Neuroscience
  41. The Contribution of α -Synuclein Spreading to Parkinson’s Disease Synaptopathy
    Francesca Longhena, Gaia Faustini, Cristina Missale, Marina Pizzi, PierFranco Spano, Arianna Bellucci · 2017 · Neural Plasticity
  42. Molecular pathogenesis of Parkinson's disease: update
    Shinji Saiki, Shigeto Sato, Nobutaka Hattori · 2011 · Journal of Neurology Neurosurgery & Psychiatry
  43. Mitochondrial Dynamics and Parkinson's Disease: Focus on Parkin
    Kah‐Leong Lim, Xiao‐Hui Ng, Lim Gui-Yin Grace, Tso‐Pang Yao · 2011 · Antioxidants and Redox Signaling
  44. Dorfin Localizes to Lewy Bodies and Ubiquitylates Synphilin-1
    Takashi Ito, Jun-ichi Niwa, Nozomi Hishikawa, Shinsuke Ishigaki, Manabu Doyu, Gen Sobue · 2003 · Journal of Biological Chemistry
  45. Proteasome Failure Promotes Positioning of Lysosomes around the Aggresome via Local Block of Microtubule-Dependent Transport
    Nava Zaarur, Anatoli B. Meriin, Eloy Bejarano, Xiaobin Xu, Vladimir L. Gabai, Ana María Cuervo, Michael Y. Sherman · 2014 · Molecular and Cellular Biology
  46. Redefining Non-Motor Symptoms in Parkinson’s Disease
    Laura Peña-Zelayeta, Karen M. Delgado-Minjares, Marcos M. Villegas-Rojas, Karen León‐Arcia, Alberto Santiago-Balmaseda, Jesús Andrade-Guerrero, Isaac Pérez-Segura, Emmanuel Ortega‐Robles, Luis Oskar Soto-Rojas, Óscar Arias-Carrión · 2025 · Journal of Personalized Medicine
  47. Parkin interacts with LIM Kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination
    Meng K. Lim, Takeshi Kawamura, Yosuke Ohsawa, Masafumi Ohtsubo, Shuichi Asakawa, Atsushi Takayanagi, Nobuyoshi Shimizu · 2007 · Experimental Cell Research
  48. Parkin and defective ubiquitination in Parkinson’s disease
    Ted M. Dawson · 2006 · Springer eBooks
  49. A Product of the Human Gene Adjacent to parkin Is a Component of Lewy Bodies and Suppresses Pael Receptor-induced Cell Death
    Yuzuru Imai, Mariko Soda, Tetsuro Murakami, Mikio Shoji, Koji Abe, Ryōsuke Takahashi · 2003 · Journal of Biological Chemistry
  50. Parkinson’s Disease and Cognitive Impairment
    Yang Yang, Beisha Tang, Jifeng Guo · 2016 · Parkinson s Disease
  51. Melatonin and Parkinson Disease: Current Status and Future Perspectives for Molecular Mechanisms
    Omid Reza Tamtaji, Russel Joseph Reiter, Reza Alipoor, Ehsan Dadgostar, Ebrahim Kouchaki, Zatollah Asemi · 2019 · Cellular and Molecular Neurobiology
  52. Parkin is recruited to the centrosome in response to inhibition of proteasomes
    Jinghui Zhao, Yong Ren, Qian Jiang, Jian Feng · 2003 · Journal of Cell Science
  53. Common anti-apoptotic roles of parkin and α-synuclein in human dopaminergic cells
    Yutaka Machida, Tomoki Chiba, Atsushi Takayanagi, Yoshikazu Tanaka, Masato Asanuma, Norio Ogawa, Akihiko Koyama, Takeshi Iwatsubo, Shosuke Ito, Poul Hening Jansen et al. · 2005 · Biochemical and Biophysical Research Communications
  54. The multi‐faceted role of mitochondria in the pathology of Parkinson’s disease
    Dennison Trinh, Ahmad R. Israwi, Lindsay R. Arathoon, Jacqueline A. Gleave, Joanne E. Nash · 2020 · Journal of Neurochemistry
  55. The role of amyloids in Alzheimer's and Parkinson's diseases
    Parveen Salahuddin, Munazza Tamkeen Fatima, Vladimir Nikolaevich Uversky, Rizwan Hasan Khan, Zeyaul Islam, Mohammad Furkan · 2021 · International Journal of Biological Macromolecules
  56. Membrane trafficking in neuronal maintenance and degeneration
    Dong Wang, Chih‐Chiang Chan, Smita Cherry, P. Robin Hiesinger · 2012 · Cellular and Molecular Life Sciences
  57. Subthalamic oscillatory activity and connectivity during gait in Parkinson's disease
    Franz Hell, Annika Plate, Jan Hinnerk Mehrkens, Kai Bötzel · 2018 · NeuroImage Clinical
  58. Multiple system atrophy: An update
    Gregor Karl Wenning, Felix Geser, Michaela Stampfer‐Kountchev, Fran�ois Tison · 2003 · Movement Disorders
  59. The ubiquitin–proteasome system and neurodegenerative disorders
    Robert Layfield, James S Lowe, Lynn Bedford · 2005 · Essays in Biochemistry
  60. Decline of striatal dopamine release in parkin‐deficient mice shown by ex vivo autoradiography
    Shigeto Sato, Tomoki Chiba, Shingo Nishiyama, Takeharu Kakiuchi, Hideo Tsukada, Taku Hatano, Takahiro Fukuda, Yasunobu Yasoshima, Nobuyuki Kai, Kazuto Kobayashi et al. · 2006 · Journal of Neuroscience Research
  61. Involvement of Endoplasmic Reticulum Stress on the Cell Death Induced by 6-Hydroxydopamine in Human Neuroblastoma SH-SY5Y Cells
    Yamamuro, Akiko, Yoshioka, Yasuhiro, Ogita, Kiyokazu, Maeda, Sadaaki · 2006 · Neurochemical Research
  62. NLRP3 Inflammasomes in Parkinson’s disease and their Regulation by Parkin
    Yiqun Yan, Yi Fang, Ran Zheng, Jiali Pu, Baorong Zhang · 2020 · Neuroscience
  63. Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease
    Anna Oczkowska, Wojciech P. Kozubski, Margarita Lianeri, Jolanta Dorszewska · 2014 · Current Genomics
  64. Residual substantia nigra neuromelanin in Parkinson’s disease is cross-linked to α-synuclein
    Mauro Fasano, Sabrina Giraudo, Silvia Coha, Bruno Bergamasco, Leonardo Lopiano · 2003 · Neurochemistry International
  65. Inflammatory Mediators Leading to Protein Misfolding and Uncompetitive/Fast Off‐Rate Drug Therapy for Neurodegenerative Disorders
    Stuart A. Lipton, Zezong Gu, Tomohiro Nakamura · 2007 · International review of neurobiology
  66. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease
    F SUN, A.G. KANTHASAMY, V. ANANTHARAM, A.G. KANTHASAMY · 2007 · Pharmacology & Therapeutics
  67. Part I: Parkin-associated proteins and Parkinson's disease
    Kumlesh Kumar Dev · 2003 · Neuropharmacology
  68. Aberrant Alternative Splicing Events in Parkinson's Disease
    Ru‐Huei Fu, Shih‐Ping Liu, Shyh-Jer Huang, Hung‐Jen Chen, Pin-Ru Chen, Ya-Hsien Lin, Yu‐Chen Ho, Wen-Lin Chang, Chang‐Hai Tsai, Woei‐Cherng Shyu et al. · 2013 · Cell Transplantation
  69. Regulation of Parkin E3 ubiquitin ligase activity
    Helen Walden, R.J. Martinez-Torres · 2012 · Cellular and Molecular Life Sciences
  70. Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synuclein
    eunna chung, Youngsil Choi, Jiae Park, Wonheum Nah, Jae-Hyung Park, Yukdong Jung, Joonno Lee, Hyunji Lee, So‐Young Park, Sun‐Young Hwang et al. · 2020 · Science Advances
  71. Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson’s Disease is Mediated by α7-Nicotinic Receptors
    Eslam El Nebrisi, Hayate Javed, Shreesh Kumar Ojha, Murat Öz, Safa A. S. Shehab · 2020 · International Journal of Molecular Sciences
  72. Pro‐apoptotic protein glyceraldehyde‐3‐phosphate dehydrogenase promotes the formation of Lewy body‐like inclusions
    Katsumi Tsuchiya, Hisao Tajima, Toyoyasu Kuwae, Takao Takeshima, Toshiya Nakano, Masaharu Tanaka, Katsuyoshi Sunaga, Yōko Fukuhara, Kenji Nakashima, Eisaku Ohama et al. · 2005 · European Journal of Neuroscience
  73. Nanozyme enabled protective therapy for neurological diseases
    Fangyi Cheng, Sumasri Kotha, Miao Fu, Qi Yang, Heng Wang, Weiwei He, Xiaobo Mao · 2024 · Nano Today
  74. MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity
    Bobby Thomas, Rainer von Coelln, Allen S. Mandir, Daniel B. Trinkaus, Mohamed H. Farah, Kah Leong Lim, Noel Ylagan Calingasan, M. Flint Beal, Valina Lynn Dawson, Ted M. Dawson · 2007 · Neurobiology of Disease
  75. Loss of parkin promotes lipid rafts-dependent endocytosis through accumulating caveolin-1: implications for Parkinson’s disease
    Seon‐Heui Cha, Yu Ree Choi, Cheol Ho Heo, Seo‐Jun Kang, Eun-hye Joe, Ilo Jou, Hwan-Myung Kim, Sang Myun Park · 2015 · Molecular Neurodegeneration
  76. Neurotoxicity and behavioral deficits associated with Septin 5 accumulation in dopaminergic neurons
    Jin H. Son, Hibiki Kawamata, Myung Sik Yoo, Dae Joon Kim, Young K. Lee, Soo‐Youl Kim, Ted M. Dawson, Hui Zhang, David Sulzer, Lichuan Yang et al. · 2005 · Journal of Neurochemistry
  77. THE DOPAMINERGIC NIGROSTRIATAL SYSTEMAND PARKINSON'S DISEASE
    Mojgan Hodaie, Joseph Samir Neimat, Andrés M. Lozano · 2007 · Neurosurgery
  78. The Role of Ubiquitin-Protein Ligases in Neurodegenerative Disease
    H.C. Ardley, Philip Alan Robinson · 2004 · Neurodegenerative Diseases
  79. Genetic screens in Caenorhabditis elegans models for neurodegenerative diseases
    Olga Sin, Helen Michels, Ellen A. A. Nollen · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  80. Parkin-Dependent Degradation of the F-Box Protein Fbw7β Promotes Neuronal Survival in Response to Oxidative Stress by Stabilizing Mcl-1
    Susanna Ekholm‐Reed, Matthew S. Goldberg, Michael G. Schlossmacher, Steven I. Reed · 2013 · Molecular and Cellular Biology
  81. Parkinson's disease: one biochemical pathway to fit all genes?
    Rejko Krüger, Olaf Eberhardt, Olaf Rieß, Jörg Bernhard Schulz, Olaf Rieß · 2002 · Trends in Molecular Medicine
  82. Conjugation and deconjugation of ubiquitin regulating the destiny of proteins
    Kwang‐Hyun Baek · 2003 · Experimental & Molecular Medicine
  83. α-Synuclein overexpression during manganese-induced apoptosis in SH-SY5Y neuroblastoma cells
    Yan Li, Liguang Sun, Tongjian Cai, Ying Zhang, Shijie Lv, Yu Wang, Liping Ye · 2009 · Brain Research Bulletin
  84. Parkinson’s Disease: A Complex Interplay of Mitochondrial DNA Alterations and Oxidative Stress
    Sarah Ciccone, Emiliano Maiani, Giovanna Bellusci, Marc F. Diederich, Stefania Gonfloni · 2013 · International Journal of Molecular Sciences
  85. NUB1 Suppresses the Formation of Lewy Body-Like Inclusions by Proteasomal Degradation of Synphilin-1
    Kunikazu Tanji, Tomoaki Tanaka, Fumiaki Mori, Katsumi Kito, Hitoshi Takahashi, Koichi Wakabayashi, Tetsu Kamitani · 2006 · American Journal Of Pathology
  86. Accumulation of Misfolded Protein Through Nitrosative Stress Linked to Neurodegenerative Disorders
    Takashi Uehara · 2007 · Antioxidants and Redox Signaling
  87. Activation mechanisms of the E3 ubiquitin ligase parkin
    Nikhil Panicker, Valina Lynn Dawson, Ted M. Dawson · 2017 · Biochemical Journal
  88. Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications
    Denis Ottolini, Tito Calí, Ildikò Szabó, Marisa Brini · 2016 · Biological Chemistry
  89. Dimerization of Parkinson's disease-causing DJ-1 and formation of high molecular weight complexes in human brain
    Stéphanie Baulac, Matthew J. LaVoie, Jennifer Mae Strahle, Michael G. Schlossmacher, Weiming Xia · 2004 · Molecular and Cellular Neuroscience
  90. N-Acetylcysteine and Celecoxib Lessen Cadmium Cytotoxicity Which Is Associated with Cyclooxygenase-2 Up-regulation in Mouse Neuronal Cells
    Maria E. Figueiredo‐Pereira, Zongmin Li, Marlon Jansen, Patricia Rockwell · 2002 · Journal of Biological Chemistry
  91. The Role of Alpha-Synuclein and Other Parkinson’s Genes in Neurodevelopmental and Neurodegenerative Disorders
    C. Alejandra Morato Torres, Zinah Wassouf, Faria Zafar, Danuta Sastre, Tiago F. Outeiro, Birgitt Schüle · 2020 · International Journal of Molecular Sciences
  92. Cross‐functional E3 ligases Parkin and C‐terminus Hsp70‐interacting protein in neurodegenerative disorders
    Pravir Kumar, Kaveri Pradhan, Karunya Ramani, Rashmi K. Ambasta, Henry W. Querfurth · 2011 · Journal of Neurochemistry
  93. Mechanisms of Parkinson’s disease-related proteins in mediating secondary brain damage after cerebral ischemia
    TaeHee Kim, Raghu Vemuganti · 2017 · Journal of Cerebral Blood Flow & Metabolism
  94. Parkinson's disease‐associated protein Parkin: an unusual player in cancer
    Juan Liu, Cen Zhang, Wenwei Hu, Zhaohui Feng · 2018 · 癌症:英文版
  95. Parkinson's disease: from causes to mechanisms
    Olga Corti, Cornelia Hampe, Frederic D. Darios, Pablo Ibáñez, Merle Ruberg, Alexis Brice · 2004 · Comptes Rendus Biologies
  96. LRRK2 in Parkinson’s disease: biochemical functions
    Vasanti S. Anand, Steven P. Braithwaite · 2009 · FEBS Journal
  97. Oxidative Stress Mechanisms Underlying Parkinson’s Disease-Associated Neurodegeneration in C. elegans
    Sudipta Chakraborty, Julia Bornhorst, Thuy Nguyen, Michael Aschner · 2013 · International Journal of Molecular Sciences
  98. The role of ubiquitin linkages on α‐synuclein induced‐toxicity in a Drosophila model of Parkinson’s disease
    Francesca K. M. Lee, Azaria Kam Yan Wong, Yuk Wa Lee, Oi Wan Wan, Ho Yin Edwin Chan, Kenny K. K. Chung · 2009 · Journal of Neurochemistry
  99. The ubiquitin ligase E6‐AP promotes degradation of α‐synuclein
    Shalaka A. Mulherkar, Jaiprakash Sharma, Nihar Ranjan Jana · 2009 · Journal of Neurochemistry
  100. Parkin contributes to synaptic vesicle autophagy in Bassoon-deficient mice
    Sheila Hoffmann-Conaway, Marisa M. Brockmann, Katharina Schneider, Anil Annamneedi, Kazi Atikur Rahman, Christine Bruns, Kathrin Textoris‐Taube, Thorsten Trimbuch, Karl‐Heinz Smalla, Christian Rosenmund et al. · 2020 · eLife